The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/36532
StudyName: Eligibility Myelodysplastic Syndromes NCT02328950
Date of export from the portal: 02.07.2020
Copyright Holder: See clinicaltrials.gov
Date of Upload / last change: 20.05.2019
License: Creative Commons BY 4.0

----

Description: 
A 5 Day Course of Fludarabine and Cytarabine Followed by Full Intensity Allogeneic Stem Cell Transplantation (FA5-Bucy) in Treating Patients With High-risk, Recurrent or Refractory Acute Leukemia and Advanced Myelodysplastic Syndrome; ODM derived from: https://clinicaltrials.gov/show/NCT02328950
